Company: IPSC
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001104659-25-037419
Chunk: 54

Company: Century Therapeutics, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 54
---
 a timely basis during the fiscal year ended December 31, 2024, except that, due to an administrative error, one Form 4 for Gregory Russotti was filed late on July 31, 2024. Notice of Annual Meeting of Stockholders and 2025 Proxy Statement | 34

TABLE OF CONTENTS

| ​ | ITEMS TO BE VOTED ON | ​ |

PROPOSAL 1: ELECTION OF CLASS I DIRECTORS FOR A THREE-YEAR TERM EXPIRING IN 2028 At the Annual Meeting, our stockholders will vote on the election of two Class I director nominees named in this Proxy Statement as directors, each to serve until our 2028 Annual Meeting of Stockholders and until their respective successors are elected and qualified. Our Board has unanimously nominated Daphne Quimi and Carlo Rizzuto, Ph.D. for election to our Board at the Annual Meeting. Each of the nominees has agreed to be named and to serve, and we expect each nominee to be able to serve if elected. If any nominee is unable to serve, the Nominating and Corporate Governance Committee will recommend to our Board a replacement nominee. The Board may then designate the other nominee to stand for election. If you voted for the unavailable nominee, your vote will be cast for his or her replacement.

| ​ | ​ | OUR BOARD UNANIMOUSLY RECOMMENDS STOCKHOLDERS VOTEFORTHEELECTION OF DAPHNE QUIMI AND CARLO RIZZUTO, PH.D. | ​ | ​ | ✓ | ​ | ​ |

Notice of Annual Meeting of Stockholders and 2025 Proxy Statement | 35

TABLE OF CONTENTS

| ​ | ITEMS TO BE VOTED ON | ​ |

PROPOSAL 2: RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025 The Audit Committee of the Board has appointed and engaged EY to serve as our independent registered public accounting firm to audit the consolidated financial statements of the Company and our subsidiary for the 2025 fiscal year, and to perform audit-related services. EY has served as our independent registered public accounting firm since 2019. Stockholders are hereby asked to ratify the Audit Committee’s appointment of EY as our independent registered public accounting firm for the 2025 fiscal year. The Audit Committee is solely responsible for selecting our independent auditors. Although stockholder ratification of the appointment of